Share-based Payment Arrangement, Expense of Apimeds Pharmaceuticals US, Inc. from 31 Dec 2023 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Apimeds Pharmaceuticals US, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2023 to 30 Jun 2025.
  • Apimeds Pharmaceuticals US, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2025 was $178,424.
  • Apimeds Pharmaceuticals US, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $0, a 100% decline from 2023.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Apimeds Pharmaceuticals US, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $178,424 01 Apr 2025 30 Jun 2025 10-Q 19 Aug 2025 2025 Q2
Q1 2025 $0 $0 01 Jan 2025 31 Mar 2025 10-Q 20 May 2025 2025 Q1
Q1 2024 $0 01 Jan 2024 31 Mar 2024 10-Q 20 May 2025 2025 Q1

Apimeds Pharmaceuticals US, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $0 -$69,993 -100% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
2023 $69,993 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.